跳至主要内容
临床试验/NCT01187537
NCT01187537已完成不适用

Effects of Continuous Femoral Nerve Block Versus Single-Injection Femoral Nerve Block With Intravenous Patient Controlled Analgesia Versus Intravenous Patient Controlled Analgesia on Knee Pain and Function After Total Knee Replacement

Tan Tock Seng Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2009年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Incidence of patients with significant pain on movement on day 1 post surgery

研究概览

简要总结

The purpose of this study is to compare the effectiveness of three analgesia techniques on pain relief and functional recovery after knee replacement: continuous femoral nerve block vs single-injection femoral nerve block with intravenous patient controlled analgesia vs intravenous patient controlled analgesia.

详细描述

Primary Outcome Measures:

  • Incidence of patients with significant pain on movement on day 1 post surgery
  • Range of knee flexion

Secondary Outcome Measures:

  • Pain intensity (rest/movement)
  • Functional recovery
  • Knee Injury and Osteoarthritis Score
  • Side effects/ Adverse outcomes
  • SF12 Quality of Life Questionnaire
  • Length of stay

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 40 years and above
  • Osteoarthritis
  • Primary unilateral total knee replacement
  • No other lower extremity joint disease
  • ASA I-III
  • Body mass index < 35
  • No severe cardiac or pulmonary diseases
  • No chronic narcotic therapy or illicit drug use
  • Mentally competent to understand study procedures and use of pain scales
  • Able to provide informed consent

排除标准

  • Any cause for knee replacement other than osteoarthritis
  • Total knee revision
  • Any contraindication for femoral block
  • Abnormal coagulation studies
  • Thrombocytopenia less than 100,000/cc
  • Known hepatic or renal insufficiency
  • Neurological disease involving lower extremities
  • Major surgery during the last 2 weeks pre-operatively
  • History of allergy to study medications
  • History of post-operative bleeding over 2000 cc/24 hours
  • History of opioid or alcohol abuse
  • Currently taking or has taken opioid > 30 consecutive days of daily use at a daily dose > 15mg morphine, within the past 2 weeks prior to surgery
  • Previously has not responded to opioid analgesics for treatment of pain
  • Pregnancy or breastfeeding

结局指标

主要结局

Incidence of patients with significant pain on movement on day 1 post surgery

时间窗: Post op day 1

次要结局

  • Functional recovery(During hospitalization, week 2, week 12)

研究者

发起方
Tan Tock Seng Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chan Ee Yuee

Dr

Tan Tock Seng Hospital

研究点 (1)

Loading locations...

相似试验